Concepedia
Statistics
Publications
7
Citations
1.2K
H-Index
Active since
1988
Affiliations
Princess Margaret Cancer Centre(Current)
GlaxoSmithKline (Poland)
GlaxoSmithKline (Germany)
G. Dane is an author at Princess Margaret Cancer Centre specializing in medicine, pharmacology, and oncology.
Publications per year
1988–2007
Phase III Trial Comparing Supportive Care Alone With Supportive Care With Oral Topotecan in Patients With Relapsed Small-Cell Lung Cancer
Mary O’Brien, Tudor–Eliade Ciuleanu, H. Tsekov et al. · Journal of Clinical Oncology · 2006 · 639 citations · Full text
Medicine, Oncology, Pharmacotherapy +14
Phase III Study of Oral Compared With Intravenous Topotecan As Second-Line Therapy in Small-Cell Lung Cancer
John R. Eckardt, Joachim von Pawel, Jean-Louis Pujol et al. · Journal of Clinical Oncology · 2007 · 384 citations
Medicine, Oncology, Pharmacology +13
Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non–Small-Cell Lung Cancer
Rodryg Ramlau, Radj Gervais, Maciej Krzakowski et al. · Journal of Clinical Oncology · 2006 · 109 citations · Full text
Medicine, Oncology, Pharmacology +12
Evidence for homogeneity of thromboxane A2 receptor using structurally different antagonists
G. T. G. Swayne, J.P. Maguire, John S. Dolan et al. · European Journal of Pharmacology · 1988 · 61 citations
Medicine, Medicinal Chemistry, Pharmacology +12
O-157 Survival benefit of oral topotecan plus supportive care versus supportive care alone in relapsed, resistant SCLC
M. O’Brien, T-E. Ciuleanu, H. Tsekov et al. · Lung Cancer · 2005 · 20 citations
Medicine, Oncology, Pharmacology +6
1–5 of 7